since 1911
• Willner Chemists •
the nutritional supplement professionals
Stevia: New Flavors Now Available
Extracts of leaves from Stevia rebaudiana have been used for many years in traditional treatment of diabetes in South America. Various compounds in stevia has been
concentrated, and used as natural sweeteners. These compounds possess up to 250 times the sweetness intensity of sucrose, and they are noncaloric and noncariogenic.
Stevioside, a natural plant glycoside isolated from the plant Stevia rebaudiana, has been commercialized as a noncaloric sweetener in Japan for more than 20 years.
Some studies have shown that stevia may be beneficial to those with hypertension, and those with type-2 diabetes. Dosage: Add 2-8 drops, as needed. Each ml is equiv-
alent to 300 mg of Stevia. Willner Chemists has offered stevia as a liquid herbal concentrate, providing Stevia Leaf Extract, standardized to 90% Steviosides, in 1, 2 and 4
oz sizes:
Phyto-Tech™ Stevia Extract 90
1 fl oz, prod code: 56943. List Price: $8.30 - Disc Price: $6.64 ~ 4 fl oz, prod code: 56942. List Price: $22.90 - Disc Price: $18.32
2 fl oz, prod code: 56940. List Price: $12.80 - Disc Price: $10.24
~~~~~~~~~~~~~~~~~~~
Now, Willner Chemists is pleased to offer six new stevia leaf extracts, in flavored form:
Phyto-Tech™ Stevia Extract - Chocolate, 2 oz, Alcohol Free (#60140)
Phyto-Tech™ Stevia Extract - Cinnamon, 2 oz, Alcohol Free (#60139)
Phyto-Tech™ Stevia Extract - Lemon, 2 oz, Alcohol Free (#60141)
Phyto-Tech™ Stevia Extract - Orange, 2 oz, Alcohol Free (#60144)
Phyto-Tech™ Stevia Extract - Peppermint, 2 oz, Alcohol Free (#60143)
Phyto-Tech™ Stevia Extract - Vanilla, 2 oz, Alcohol Free (#60142)
These new Stevia liquids are 100% Gluten Free, and contain only organic stevia leaf extract, veg-
etable glycerin, purified water and natural flavors/essential oils. The list price on the new, flavored
versions is $12.80 and the Willner discount price is $10.24.
Suggested Use: As a dietary supplement, add 5-8 drops to a beverage or food. Shake well before
using.
~~~~~~~~~~~~~
To listen to an interview on stevia and other therapeutic herbal supplements, go to www.willner.com and look up the May 22, 2011
Willner Window Radio Program
binding to TPX2-Aurora A Complex (29).
Other studies show ashwagandha’s cytotoxic-
ity is related to its structure; it enhances
ATPase and inhibits succinate dehydrogenase
activities, impairing oxidative phosphoryla-
tion. In animal studies, ashwagandha can
enhance the effects of radiation therapy (20)
by reducing tumor GSH levels (10).
Ashwagandha can reverse paclitaxel-induced
neutropenia in mice (12). Significant toxicity
was observed at high doses in animal studies
(20); however, toxicity studies in humans are
limited (2).
Do not use during pregnancy. Keep out of
the reach of children. Use caution if taking
anti-coagulant medication. May have a slight
blood glucose lowering action.
References: General
MSKCC.ORG (Memorial Sloan-Kettering Cancer
Center
NHIondemand.com
Brown, Donald N.D., Herbal Prescriptions for Better
Health, Prima Publishing.
References: Maitake
Hobbs C. Medicinal Mushrooms, 3rd ed. Loveland
(CO): Interweave Press; 1996.
Adachi K, Nanba H, Kuroda H. Potentiation of host-
mediated antitumor activity in mice by beta glucan
obtained from Grifola frondosa (maitake). Chem Pharm
Bull 1987;35:262-70.
Kubo K, Aoki H. Nanba H. Anti-diabetic activity pres-
ent in the fruit body of Grifola frondosa (Maitake). Biol
Pharm Bull 1994;17:1106-10.
Horio H, Ohtsuru M. Maitake (Grifola frondosa)
improve glucose tolerance of experimental diabetic rats.
J Nutr Sci Vitaminol 2001;47:57-63.
Kodama N, Komuta K, Nanba H. Can Maitake MD-
fraction aid cancer patients? Altern Med Rev
2002;7:236-9.
Miura NN. Blood clearance of (1—>3)-beta-D-glucan
in MRL lpr/lpr mice. FEMS Immunol Med Microbiol
1996;13:51-7.
Ohno N, et al. Characterization of the antitumor glu-
can obtained from liquid-cultured Grifola frondosa.
Chem Pharm Bull 1986;34:1709-1715.
Nanba H, Kubo K. Maitake D-fraction: Healing and
preventive potential for cancer. J Orthomolecular Med
1997;12:43-9.
Konno S, et al. A possible hypoglycaemic effect of
maitake mushroom on Type 2 diabetic patients. Diabet
Med 2001 Dec;18(12):1010
Yamada Y, et al. Antitumor effect of orally adminis-
tered extracts from fruit body of grifola frondosa
(maitake). Chemotherapy 1990;38:790-6.
Lin H, et al. Maitake beta-glucan MD-fraction
enhances bone marrow colony formation and reduces
doxorubicin toxicity in vitro. Int Immunopharmacol 2004
Jan;4(1):91-9.
Hong L, Xun M, Wutong W. Anti-diabetic effect of an
alpha-glucan from fruit body of maitake (Grifola fron-
dosa) on KK-Ay mice. Pharm Pharmacol. 2007
Apr;59(4):575-82.
Masuda Y, Murata Y, Hayashi M, Nanba H. Inhibitory
effect of MD-Fraction on tumor metastasis: involvement
of NK cell activation and suppression of intercellular
adhesion molecule (ICAM)-1 expression in lung vascular
endothelial cells. Biol Pharm Bull 2008 Jun;31(6):1104-
8.
Deng G, Lin H, Seidman A, et al. A phase I/II trial of a
polysaccharide extract from Grifola frondosa (Maitake
mushroom) in breast cancer patients: immunological
effects. J Cancer Res Clin Oncol 2009, March 1.
Harada N, Kodama N, Nanba H. Relationship
between dendritic cells and the D-fraction-induced Th-1
dominant response in BALB/c tumor-bearing mice.
Cancer Lett. 2003;192(2):181-7.
Shomori K, Yamamoto M, Arifuku I, Teramachi K, Ito
H. Antitumor effects of a water-soluble extract from
Maitake (Grifola frondosa) on human gastric cancer cell
lines. Oncol Rep. 2009 Sep;22(3):615-20.
Lin H, de Stanchina E, Zhou XK, et al. Maitake beta-
glucan promotes recovery of leukocytes and myeloid cell
function in peripheral blood from paclitaxel hematotoxi-
city. Cancer Immunol Immunother. 2010 Feb 6. [Epub
ahead of print]
Louie B, Rajamahanty S, Won J, Choudhury M, Konno
S. Synergistic potentiation of interferon activity with
maitake mushroom d-fraction on bladder cancer cells.
BJU Int. 2009 Sep 4. [Epub ahead of print]
Lee JS, Park SY, Thapa D, et al. Grifola frondosa water
extract alleviates intestinal inflammation by suppressing
TNF-alpha production and its signaling. Exp Mol Med.
2010 Feb 28;42(2):143-54.
Masuda Y, Ito K, Konishi M, Nanba H. A polysaccha-
ride extracted from Grifola frondosa enhances the anti-
tumor activity of bone marrow-derived dendritic cell-
based immunotherapy against murine colon cancer.
Cancer Immunol Immunother. 2010 Oct;59(10):1531-
41.
Hanselin MR, Vande Griend JP, Linnebur SA. INR ele-
vation with maitake extract in combination with war-
farin. Ann Pharmacother. 2010 Jan;44(1):223-4.
Chen JT, Tominaga K, Sato Y, Anzai H, Matsuoka R.
Maitake mushroom (Grifola frondosa) extract induces
ovulation in patients with polycystic ovary syndrome: a
possible monotherapy and a combination therapy after
failure with first-line clomiphene citrate. J Altern
Complement Med. 2010 Dec;16(12):1295-9.
References: Shiitake
Ng ML, Yap AT. Inhibition of human colon carcinoma
development by lentinan from shiitake mushrooms
(Lentinus edodes). J Altern Complement Med
2002;8(5):581-589.
Okamoto T, Kodoi R, Nonaka Y, et al. Lentinan from
shiitake mushroom (Lentinus edodes) suppresses expres-
sion of cytochrome P450 1A subfamily in the mouse
liver. Biofactors. 2004;21(1-4):407-409.
Ngai PH, Ng TB. Lentin, a novel and potent antifungal
protein from shitake mushroom with inhibitory effects on
activity of human immunodeficiency virus-1 reverse tran-
scriptase and proliferation of leukemia cells. Life Sci. Nov
14 2003;73(26):3363-3374.
Israilides C, Kletsas D, Arapoglou D, et al. In vitro cyto-
static and immunomodulatory properties of the medici-
nal mushroom Lentinula edodes. Phytomedicine 2008.
Akamatsu S, Watanabe A, Tamesada M, et al.
Hepatoprotective effect of extracts from Lentinus edodes
mycelia on dimethylnitrosamine-induced liver injury. Biol
Pharm Bull. 2004;27(12):1957-1960.
de Lima PL, Delmanto RD, Sugui MM, et al. Letinula
edodes (Berk.) Pegler (Shiitake) modulates genotoxic and
mutagenic effects induced by alkylating agents in vivo.
Mutat Res. 2001;496(1-2):23-32.
Shouji N, Takada K, Fukushima K, Hirasawa M.
Anticaries effect of a component from shiitake (an edible
mushroom). Caries Res 2000;34(1):94-98.
deVere White RW, Hackman RM, Soares SE, Beckett
LA, Sun B. Effects of a mushroom mycelium extract on
the treatment of prostate cancer. Urology
2002;60(4):640-644.
Gordon M, Bihari B, Goosby E, et al. A placebo-con-
trolled trial of the immune modulator, lentinan, in HIV-
positive patients: a phase I/II trial. J Med 1998;29(5-
6):305-330.
Suzuki K, Tanaka H, Sugawara H, et al. Chronic hyper-
sensitivity pneumonitis induced by Shiitake mushroom
spores associated with lung cancer. Intern Med
2001;40(11):1132-1135.
Hanada K, Hashimoto I. Flagellate mushroom
(Shiitake) dermatitis and photosensitivity. Dermatology.
1998;197(3):255-257.
Levy AM, Kita H, Phillips SF, et al. Eosinophilia and
gastrointestinal symptoms after ingestion of shiitake
mushrooms. J Allergy Clin Immunol 1998;101(5):613-
620.
Hobbs C. Medicinal Mushrooms, 3rd ed. Loveland
(CO): Interweave Press; 1996.
Sia GM, Candish JK. Effects of shiitake (Lentinus edo-
des) extract on human neutrophils and the U937 mono-
cytic cell line. Phytother Res 1999;13(2):133-7.
Isoda N, Eguchi Y, Nukaya H, et al. Clinical efficacy of
superfine dispersed lentinan (beta-1,3-glucan) in patients
with hepatocellular carcinoma. Hepatogastroenterology.
2009 Mar-Apr;56(90):437-41.
Oba K, Kobayashi M, Matsui T, Kodera Y, Sakamoto J.
Individual patient based meta-analysis of lentinan for
unresectable/recurrent gastric cancer. Anticancer Res.
2009 Jul;29(7):2739-45.
Hazama S, Watanabe S, Ohashi M, et al. Efficacy of
orally administered superfine dispersed lentinan (beta-
1,3-glucan) for the treatment of advanced colorectal can-
cer. Anticancer Res. 2009 Jul;29(7):2611-7.
Shimizu K, Watanabe S, Watanabe S, et al. Efficacy of
oral administered superfine dispersed lentinan for
advanced pancreatic cancer. Hepatogastroenterology.
2009 Jan-Feb;56(89):240-4.
Garg S, Cockayne SE. Shiitake dermatitis diagnosed
after 16 years! Arch Dermatol. 2008 Sep;144(9):1241-2.
Goikoetxea MJ, Fernández-Benítez M, Sanz ML. Food
allergy to Shiitake (Lentinus edodes) manifested as
oesophageal symptoms in a patient with probable
eosinophilic oesophagitis. Allergol Immunopathol (Madr).
2009 Nov-Dec;37(6):333-4.
References: Reishi Mushroom
Huang K. The Pharmacology of Chinese Herbs. 2nd
ed. New York: CRC Press; 1999.
Chen HS, Tsai YF, Lin S, et al. Studies on the immuno-
modulating and anti-tumor activities of Ganoderma
lucidum (Reishi) polysaccharides. Bioorg Med Chem.
Nov 1 2004;12(21):5595-5601.
Gao Y, Zhou S, Wen J, et al. Mechanism of the antiul-
cerogenic effect of Ganoderma lucidum polysaccharides
on indomethacin-induced lesions in the rat. Life Sci. Dec
27 2002;72(6):731-745.
Hsu MJ, Lee SS, Lin WW. Polysaccharide purified from
Ganoderma lucidum inhibits spontaneous and Fas-medi-
ated apoptosis in human neutrophils through activation
of the phosphatidylinositol 3 kinase/Akt signaling path-
way. J Leukoc Biol. Jul 2002;72(1):207-216.
Wang SY, Hsu ML, Hsu HC, et al. The anti-tumor
effect of Ganoderma lucidum is mediated by cytokines
released from activated macrophages and T lympho-
cytes. Int J Cancer. Mar 17 1997;70(6):699-705.
Wachtel-Galor S, Szeto YT, Tomlinson B, et al.
Ganoderma lucidum ('Lingzhi'); acute and short-term
biomarker response to supplementation. Int J Food Sci
Nutr. Feb 2004;55(1):75-83.
Wachtel-Galor S, Tomlinson B, Benzie IF. Ganoderma
lucidum (“Lingzhi”), a Chinese medicinal mushroom:
biomarker responses in a controlled human supplemen-
tation study. Br J Nutr. Feb 2004;91(2):263-269.
Gao Y, Zhou S, Jiang W, et al. Effects of ganopoly (a
Ganoderma lucidum polysaccharide extract) on the
immune functions in advanced-stage cancer patients.
Immunol Invest. Aug 2003;32(3):201-215.
Noguchi M, Kakuma T, Tomiyasu K, et al. Randomized
clinical trial of an ethanol extract of Ganoderma lucidum
in men with lower urinary tract symptoms. Asian J
Androl. Sep 2008;10(5):777-785.
Noguchi M, Kakuma T, Tomiyasu K, et al. Effect of an
extract of Ganoderma lucidum in men with lower uri-
nary tract symptoms: a double-blind, placebo-controlled
randomized and dose-ranging study. Asian J Androl. Jul
2008;10(4):651-658.
Hobbs C. Medicinal Mushrooms. 3rd ed. Loveland
(OR): Interweave Press; 1996.
Tao J, Feng KY. Experimental and clinical studies on
inhibitory effect of ganoderma lucidum on platelet aggre-
gation. J Tongji Med Univ. 1990;10(4):240-243.
Wang CZ, Basila D, Aung HH, et al. Effects of gano-
derma lucidum extract on chemotherapy-induced nau-
sea and vomiting in a rat model. Am J Chin Med.
2005;33(5):807-815.
Gill SK, Rieder MJ. Toxicity of a traditional Chinese
medicine, Ganoderma lucidum, in children with cancer.
Can J Clin Pharmacol. Summer 2008;15(2):e275-285.
Wang X, Zhao X, Li D, et al. Effects of Ganoderma
lucidum polysaccharide on CYP2E1, CYP1A2 and CYP3A
activities in BCG-immune hepatic injury in rats. Biol
Pharm Bull. Sep 2007;30(9):1702-1706.
Chen NH, Liu JW, Zhong JJ. Ganoderic Acid me
inhibits tumor invasion through down-regulating matrix
metalloproteinases 2/9 gene expression. J Pharmacol Sci.
Oct 2008;108(2):212-216.
Li YB, Wang R, Wu HL, et al. Serum amyloid A medi-
ates the inhibitory effect of Ganoderma lucidum polysac-
charides on tumor cell adhesion to endothelial cells.
Oncol Rep. Sep 2008;20(3):549-556.
Mao T, van De Water J, Keen CL, et al. Two mush-
rooms, Grifola frondosa and Ganoderma lucidum, can
stimulate cytokine gene expression and proliferation in
human T lymphocytes. Int J Immunother 1999;15(1):13-
22.
Chan WK, Cheung CC, Law HK, et al. Ganoderma
lucidum polysaccharides can induce human monocytic
leukemia cells into dendritic cells with immuno-stimula-
tory function. J Hematol Oncol. 2008;1(1):9.
Noguchi M, Kakuma T, Tomiyasu K, et al. Effect of an
extract of Ganoderma lucidum in men with lower uri-
nary tract symptoms: a double-blind, placebo-controlled
randomized and dose-ranging study. Asian J Androl.
2008 Jul;10(4):651-8.
Weng CJ, Yen GC. The in vitro and in vivo experimen-
. . . continued on page 89